CHEK1 and colorectal carcinoma: CHEK1, as a regulator of the cell cycle and DNA damage response, can be inhibited to disrupt cell cycle progression and sensitize CRC cells to DNA-damaging agents, potentially curtailing proliferation and enhancing cell death.